ArticleOncotarget2019

The histone deacetylase inhibitor Romidepsin induces as a cascade of differential gene expression and altered histone H3K9 marks in myeloid leukaemia cells.

Kathryn Clarke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.